To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Aeterna Zentaris Receives Positive Scientific Advice for its Phase 3 Trial with Perifosine in Colorectal Cancer
Aeterna Zentaris Inc. announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lead anticancer proprietary compound, perifosine, in refractory advanced colorectal cancer. The trial i more
Aeterna Zentaris Reports Final Results of a Phase 2 Study of Perifosine in the Treatment of Colorectal Cancer
Aeterna Zentaris Inc. reported final results on the clinical activity of perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, in combination with capecitabine (Xeloda(R)) as a treat more
ElexoPharm Appoints Prof. Jürgen Engel as Chairman of the Advisory Board
ElexoPharm GmbH announced the appointment of Professor Dr. Jürgen Engel as Chairman of its Advisory Board. He is going to support ElexoPharm’s efforts to expand its activities in preclinical drug development and to build up strong alliances with big pharmaceutical companies. As Chairman of the Advis more
News 04/21/2005 Æterna Zentaris and the University of Würzburg Agree on Research Cooperation for Tumor Vaccines The Universität of Würzburg the Canadian-German company Æterna Zentaris Inc . (TSX: AEZ; NASDAQ: AEZS) announced today the beginning of a research cooperation for the preclinical and ea more
Corporate Profile Æterna Zentaris Inc. (TSX: AEZ, NASDAQ: AEZS) is a late-stage drug development company specialized in oncology and endocrinology. Contact us: Æterna Zentaris Inc. 1405 du Parc-Technologique Blvd. Québec, Québec Canada G1P 4P5 Phone: (418) 652-8525 Fax: (418) 652-0881 www.aezsinc.co more
ElexoPharm appoints Prof. Jürgen Engel as Chairman of the Advisory Board ElexoPharm GmbH announced today the appointment of Professor Dr. Jürgen Engel as Chairman of its Advisory Board. He is going to support ElexoPharm’s efforts to expand its activities in preclinical drug development and to b more